Boston Scientific Corp
Change company Symbol lookup
Select an option...
BSX Boston Scientific Corp
LE Lands End Inc
WING Wingstop Inc
PUMP ProPetro Holding Corp
CHK Chesapeake Energy Corp
SALM Salem Media Group Inc
UGAZ VelocityShares 3x Long Natural Gas ETN Linked to the S&P GSCI? Natural Gas Index ER
UBSI United Bankshares Inc
LTM LATAM Airlines Group SA
TRGP Targa Resources Corp
Go

Health Care : Health Care Equipment & Supplies | Large Cap Growth
Company profile

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Rhythm Management consists of Cardiac Rhythm Management and Electrophysiology businesses. MedSurg consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its Interventional Cardiology product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters and embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.

Closing Price
$37.50
Day's Change
-0.49 (-1.29%)
Bid
--
Ask
--
B/A Size
--
Day's High
38.18
Day's Low
37.42
Volume
(Light)
Volume:
6,174,670

10-day average volume:
13,239,622
6,174,670

Display:

Providers:

UpdateCancel
6 providers
Yesterday's News, June 01, 2020
Boston Scientific Launches DIRECTSENSE(TM) Technology

Boston Scientific (NYSE: BSX) announced the U.S. launch of the DIRECTSENSE(TM) Technology, a tool for monitoring the effect of radiofrequency (RF) energy delivery during cardiac ablation procedures. Available on the RHYTHMIA HDx(TM) Mapping System...(PR Newswire)

May 27, 2020
Boston Scientific Completes Approximately $2.0 Billion Aggregate Offerings of Common Stock and Mandatory Convertible Preferred Stock

Boston Scientific Corporation (NYSE: BSX) completed the concurrent offerings of (i) 29,382,500 shares of its common stock, which includes the exercise in full by the underwriters of their option to purchase up to 3,832,500 additional shares of...(PR Newswire)

May 26, 2020
Boston Scientific to Participate in Jefferies 2020 Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Jefferies 2020 Virtual Healthcare Conference on June 2. https://mma.prnewswire.com/media/329537/Boston_Scientific_Logo.jpg (PR Newswire)

May 21, 2020
Boston Scientific Prices Offerings of Common Stock and Mandatory Convertible Preferred Stock

Boston Scientific Corporation (NYSE: BSX) announced the pricing of concurrent offerings of 25,550,000 shares of its common stock ("Common Stock") at a price to the public of $34.25 per share and 8,750,000 shares of its 5.50% Mandatory Convertible...(PR Newswire)

May 20, 2020
Boston Scientific Announces Offerings of Common Stock and Mandatory Convertible Preferred Stock

Boston Scientific Corporation (NYSE: BSX) announced that it has commenced concurrent offerings of $750.0 million of shares of its common stock ("Common Stock") and $750.0 million of shares of its Series A Mandatory Convertible Preferred Stock...(PR Newswire)

May 18, 2020
Boston Scientific Completes $1.7 Billion Offering of Senior Notes

Boston Scientific Corporation (NYSE: BSX) completed a public offering of $1.7 billion aggregate principal amount of its senior notes. The public offering consists of $500.0 million of 1.900% notes due 2025 and $1.2 billion of 2.650% notes due 2030. (PR Newswire)

Analysis on Impact of COVID19 - Global Colonoscopy Devices Market 2020-2024 | Evolving Opportunities with Ambu AS and Boston Scientific Corp. | Technavio

The global colonoscopy devices market is expected to grow by USD 471.90 million as per Technavio. This marks a significant market slow down compared to the 2019 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2020...(BusinessWire)

May 14, 2020
Boston Scientific Prices $1.7 Billion of Senior Notes

Boston Scientific Corporation (NYSE: BSX) announced the pricing of a public offering of $1.7 billion aggregate principal amount of its senior notes under the company's shelf registration statement. The public offering consists of $500.0 million in...(PR Newswire)

May 12, 2020
Minerva Surgical(R) Announces Acquisition Closing of Boston Scientific Intrauterine Health Products

Minerva Surgical announced today, the closing of the acquisition of Boston Scientific's Intrauterine Health franchise. Minerva's combined product line will provide healthcare practitioners with the most complete and trusted product portfolio for...(PR Newswire)

May 11, 2020
GetUsPPE Delivers One Million Face Shields to Healthcare Facilities Nationwide

GetUsPPE, a leading volunteer organization connecting healthcare providers with supplies of PPE (personal protective equipment), has delivered one million face shields to healthcare facilities around the United States. Shields manufactured and...(PR Newswire)

May 08, 2020
PINNACLE FLX Study of the WATCHMAN FLX(TM) Left Atrial Appendage Closure Device Presented as Late-Breaking Clinical Trial at HRS 2020 SCIENCE

Today, Boston Scientific (NYSE: BSX) announced positive 12-month results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-generation WATCHMAN FLX(TM) Left Atrial Appendage Closure (LAAC) Device for patients with...(PR Newswire)

Late-Breaking Clinical Trial Data Underscore Safety And Efficacy Of Boston Scientific S-ICD System

Boston Scientific (NYSE: BSX) today announced the final results from the UNTOUCHED study of the EMBLEM(TM) Subcutaneous Implantable Defibrillator (S-ICD) System presented at HRS 2020 SCIENCE, an online series from the Heart Rhythm Society. (PR Newswire)

May 06, 2020
Boston Scientific Announces May 2020 Virtual Conference Schedule

Boston Scientific Corporation (NYSE: BSX) will participate in three upcoming virtual investor conferences. https://mma.prnewswire.com/media/329537/Boston_Scientific_Logo.jpg On May 13, 2020, Dan Brennan, executive vice president and chief financial...(PR Newswire)

April 30, 2020
The Global Safety Syringes Market is expected to grow from USD 5,236.13 Million in 2018 to USD 9,612.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 9.06%

Reportlinker.com announces the release of the report "Global Safety Syringes Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025...(Globe Newswire)

April 27, 2020
Transcatheter Heart Valve Replacement Market to Reach USD 10.34 Billion by 2026; Owing to Increasing Prevalence of Cardiovascular Diseases Among Geriatric Population: Fortune Business Insights(TM)

The global Transcatheter Heart Valve Replacement Market size is anticipated to reach USD 10.34 billion by 2026 on account of the increasing number of death cases caused due to cardiac medical conditions worldwide. THVR is a minimally invasive...(Globe Newswire)

April 23, 2020
The Global Urinary Incontinence Device Market is expected to grow from USD 2,895.68 Million in 2018 to USD 4,783.40 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.43%

Reportlinker.com announces the release of the report "Global Urinary Incontinence Device Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025...(Globe Newswire)

The Global Vascular Guidewire Market is expected to grow from USD 746.04 Million in 2018 to USD 1,294.95 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.19%

Reportlinker.com announces the release of the report "Global Vascular Guidewire Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025...(Globe Newswire)

UnitedHealth Group, Boston Scientific, Medtronic and the University of Minnesota Work to Deploy 3,000 Emergency Ventilator Alternative Devices

UnitedHealth Group is collaborating with Boston Scientific, Medtronic and the University of Minnesota to deploy 3,000 newly invented "light" ventilators to address the limited stock of critical breathing support equipment in response to COVID-19. (BusinessWire)

The Global Syringes Market is expected to grow from USD 8,423.13 Million in 2018 to USD 11,236.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 4.20%

Reportlinker.com announces the release of the report "Global Syringes Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025...(Globe Newswire)

April 21, 2020
New Renewable Energy Agreements To Reduce Boston Scientific Carbon Footprint By Half

Boston Scientific Corporation (NYSE: BSX) has signed a virtual power purchase agreement (VPPA) that represents the largest step the company has taken to achieve its goal of global carbon neutral manufacturing and distribution by 2030. The agreement...(PR Newswire)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.